Digital health case study Biopharma
Key therapeutic area Digital Health portfolio evaluation
Client context: Key Therapeutic Area Digital Health portfolio evaluation
Strategic question
As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm fitness for purpose
Approach
As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm fitness for purpose
Strategic implication
Working closely with the client’s franchise and BD teams, Galen Growth ran an analysis of the client’s existing global portfolio of ventures to assess the operational maturity of each. Over 70 ventures were assessed for their clinical, commercial and operational fitness to enable a fresh prioritisation
